RT Journal Article
SR Electronic
T1 An incomplete Circle of Willis is not a risk factor for white matter hyperintensities: The Tromsø Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.25.20183756
DO 10.1101/2020.09.25.20183756
A1 Hindenes, Lars B.
A1 Håberg, Asta K.
A1 Mathiesen, Ellisiv B.
A1 Vangberg, Torgil R.
YR 2020
UL http://medrxiv.org/content/early/2020/09/27/2020.09.25.20183756.abstract
AB Objective The Circle of Willis (CoW) is often underdeveloped or incomplete, leading to suboptimal blood supply to the brain. As hypoperfusion is thought to play a role in the aetiology of white matter hyperintensities (WMH), the objective of this study was to assess whether incomplete CoW variants were associated with increased WMH volumes compared to the complete CoW.Methods In a cross-sectional population sample of 1864 people (age 40 – 84 years, 46.4% men), we used an automated method to segment WMH using T1-weighted and T2-weighted fluid-attenuated inversion recovery image obtained at 3T. CoW variants were classified from time-of-flight scans, also at 3T. WMH risk factors, including age, sex, smoking and blood pressure, were obtained from questionnaires and clinical examinations. We used linear regression to examine whether people with incomplete CoW variants had greater volumes of deep WMH (DWMH) and periventricular WMH (PWMH) compared to people with the complete CoW, correcting for WMH risk factors.Results Participants with incomplete CoW variants did not have significantly higher DWMH or PWMH volumes than those with complete CoW when accounting for risk factors. Age, pack-years smoking, and systolic blood pressure were risk factors for increased DWMH and PWMH volume. Diabetes was a unique risk factor for increased PWMH volume.Conclusion Incomplete CoW variants do not appear to be risk factors for WMH in the general population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by two Helse Nord project grants HNF1369-17 and SFP1271-16, and computational resources from NOTUR grant #NN9562K. The funding source had no role in the study design, collection of data, analysis, interpretation of data, and in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Regional Committee of Medical and Health Research Ethics Northern Norway (2014/1665/REK-Nord) and carried out in accordance with relevant guidelines and regulations at UiT The Arctic University of Norway. All participants gave written informed consent before participating in the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers can obtain the data used in this study by applying to The Tromsø Study via a standard application procedure (https://en.uit.no/forskning/forskningsgrupper/gruppe?p_document_id=453582). https://en.uit.no/forskning/forskningsgrupper/gruppe?p_document_id=453582 http://tromsoundersokelsen.uit.no/tromso/